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Purpose: To validate, in the context of adaptive radiotherapy, three commercial software solutions for
atlas-based segmentation.
Methods and materials: Fifteen patients, five for each group, with cancer of the Head&Neck, pleura, and prostate
were enrolled in the study. In addition to the treatment planning CT (pCT) images, one replanning CT (rCT) image
set was acquired for each patient during the RT course. Three experienced physicians outlined on the pCT and rCT
all the volumes of interest (VOIs). We used three software solutions (VelocityAI 2.6.2 (V), MIM 5.1.1 (M) by MIMVista
and ABAS 2.0 (A) by CMS-Elekta) to generate the automatic contouring on the repeated CT. All the VOIs obtained
with automatic contouring (AC) were successively corrected manually. We recorded the time needed for: 1)
ex novo ROIs definition on rCT; 2) generation of AC by the three software solutions; 3) manual correction of AC.
To compare the quality of the volumes obtained automatically by the software and manually corrected with those
drawn from scratch on rCT, we used the following indexes: overlap coefficient (DICE), sensitivity, inclusiveness index,
difference in volume, and displacement differences on three axes (x, y, z) from the isocenter.
Results: The time saved by the three software solutions for all the sites, compared to the manual contouring from
scratch, is statistically significant and similar for all the three software solutions. The time saved for each site are as
follows: about an hour for Head&Neck, about 40 minutes for prostate, and about 20 minutes for mesothelioma. The
best DICE similarity coefficient index was obtained with the manual correction for: A (contours for prostate), A and
M (contours for H&N), and M (contours for mesothelioma).
Conclusions: From a clinical point of view, the automated contouring workflow was shown to be significantly
shorter than the manual contouring process, even though manual correction of the VOIs is always needed.
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Anatomical variations occurring during irradiation, in-
cluding tumor shrinkage and shape deformation, can be
significant and can result in suboptimal treatment of
patients, especially when highly conformal treatment
techniques, such as intensity modulated photon or pro-
ton therapy, are used [1,2].
Repeat imaging and replanning, even with a single
mid-treatment CT scan only, can significantly improve
tumor coverage and organ sparing in patients who
experienced clinically apparent changes in anatomy
[3,4]. However, in clinical practice adaptive planning is
limited to a small number of patients considering the
need for multiple physician-drawn volumes. To spread
out the practice of adaptive radiotherapy easing the
onerous task of recontouring is required.
In this context, a fast, robust, and automatic region-
of-interest (ROI) delineation method is needed and has
led to a growing array of automatic contouring (AC)
software [5-7]. These algorithms generally deform one
set of contours from an initial CT to fit the anatomy of
a second CT, and they can also redraw the ROI of inter-
est for each CT from scratch.
The purpose of the present study was to compare
three different commercial algorithms applying them to
a number of clinical cases. The software solutions (SS)
were evaluated quantitatively both in terms of speed and
reliability.
Methods and materials
All volumes of interest (VOIs) were outlined manually
by three in field specialized oncologists (e.g. H&N was
contoured by a H&N oncologist, etc.) on planning CT
(pCT), that represented our atlas for AC on three SS re-
planning CT (rCT).
We used three commercial software solutions to gen-
erate the automatic contours, subsequently all these
VOIs were manually corrected (ACMC) by the same
experienced physicians. The VOIs on the rCT were also
manually contoured from scratch, that represented our
reference volumes (Vref ). The times employed for AC,
for ACMC (when needed), and for Vref contouring were
recorded. To evaluate the quality of the contours, AC
and ACMC were compared, by the use of several para-
meters, with those manually delineated on rCT (Vref ).
Patient data and manual contouring
A conventional helical CT scanner was used for image
acquisition. A total of 15 patients (five with locally-
advanced head and neck (H&N) tumors, five with ma-
lignant pleural mesotheliomas (MPM) and five with
high-risk prostate cancer (HRPCa)) were enrolled in the
study. In addition to the treatment pCT images, a fur-
ther set of CT images (rCT) was acquired for eachpatient during the RT course, usually in the middle of
the treatment. For H&N, prostate and mesothelioma
patients the images had a slice thickness of 3, 2.5, and
5 mm, respectively. A commercial treatment planning
system (Focal 4D by Elekta, Sweden) was used for the
manual contouring from scratch of ROIs (Figure 1).
All H&N patients (two oropharynx, one oral cavity, one
nasopharynx, and one larynx) had pathologically con-
firmed Stage III-IV disease. The target volumes were
determined according to the ICRU definition of GTV and
CTV. For each patient, neck levels were delineated
according to international consensus guidelines [8]. In
addition, 16 organs at risk (OARs) were contoured (par-
otid, cochlea, esophagus, brainstem, spinal cord, mandible,
thyroid, pharynx, masticatory spaces, larynx, oral cavity,
temporal lobes, eyes, lenses, optic nerves and chiasm).
Five MPM patients had been previously treated with
extraperitoneal pleuro-pneumonectomy and received ad-
juvant thoracic irradiation. The CTV included the entire
hemithorax and thoracotomy incision and site of chest
drains. Two patients had a lesion on the right side and
three on the left. Contoured normal tissues were: contra-
lateral lung, heart, esophagus, liver, bowel, spinal cord,
spleen, kidneys. Five HRPCa patients (PSA>20 ng/mL;
Gleason score 8–10 or c/pT3a/b) [9] had been previously
treated, two with definitive radiotherapy and three with
post-operative irradiation. The CTV encompassed the
prostate and seminal vesicles (definitive irradiation) or
prostatic bed (post-operative irradiation) and pelvic
lymphnodes. The defined OARs were: rectum, bladder,
femoral heads and bowel.
Automatic contouring
Using three commercially available programs a) ABAS
2.0 (CMS-Elekta, Stockholm, Sweden) (A), b) MIM
5.1.1, (MIMVista corp, Cleveland, Ohio) (M), and c)
VelocityAI 2.6.2 (Velocity Medical Systems, Atlanta,
Georgia) (V), contours from the initial pCT were
deformed to the replanning CT for each patient.
In ABAS an atlas patient consists of a CT scan with
pre-defined ROIs, both target volumes and OARs. A
detailed description of the method has been published
by Han et al. [10]. Firstly, non-rigid registration is used
to transform the CT scan of an atlas patient (pCT) to re-
planning CT scan. Specific models for e.g., H&N and
prostate are available in the software, taking structure-
specific information, like elasticity, into account. Then,
using the obtained transformation, auto-contours are
generated by mapping the atlas contours to the replan-
ning CT scan.
Also in MIM, we decided to use a single-atlas segmen-
tation approach: the pCT of the patient was inserted
into the atlas and, subsequently, the algorithm extracts
information from one CT to generate the automated
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registration with rotations were applied, followed by
deformable registration. The previously validated
intensity-based free-form deformable registration algo-
rithm utilizes regularization to minimize the likelihood
of folds or tears in the deformation fields to fit one CT
to another [11].
A single-patient-atlas segmentation approach was
used also with VelocityAI. Between planning CT and re-
planning CT, we firstly applied a rigid registration with
rotations and secondly, a deformable multi pass regis-
tration. Finally, we copied the contours from planning
CT to replanning CT and this software applied automat-
ically the deformation matrix to them. VelocityAI uses
the basis-spline (B-spline) method [12] for deformable
registrations.Time/speed evaluation
Focal 4D, ABAS and MIM were installed in a 3 GHz HP
xw 8600 workstation running Windows with 8 GB
RAM, whereas VelocityAI was installed in a 2.66 GHz
HP xw 8600 workstation running Windows with 4 GB
RAM. The time required for the ex novo ROIs definition
on rCT, for the three software solutions to generate the
AC, and finally, the time for manual correction of AC
was calculated.Figure 1 Flow chart showing input data and software evaluation straThe time to manually define the volumes on rCT was
calculated from the opening of the latest CT to the last
ROI. The time needed by the software solutions to gen-
erate automatic contours was measured by when the CT
was imported until the end of the entire generation
process. The time needed to check the automatically-
obtained volumes was defined from the time of loading
the CT until the time needed for final volume correction
(Figure 1). The usefulness of the automatic contours
procedure was evaluated by comparing 1) the time
needed from the software +manual corrections vs. man-
ual contour from scratch or 2) just the manual correc-
tion time vs. manual contour from scratch (i.e. not
considering the time needed by the computer for the
generation of the deformed contours).
Quantitative evaluation of automated and manually
corrected contours
The performance of the automatic segmentation soft-
ware was assessed by quantitatively comparing manual
Vref contours with AC or ACMC contours in terms of
volume, position and shape. A sensitivity and specificity
study was also conducted. Manual segmentation was
used as the reference segmentation.
As an initial measure of the similarity between the
automatic and manual contours, the volume of every
structure was calculated and the difference between thetegy.
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ABAS, MIM and VElocityAI, respectively) and the
manually generated volume, or reference volume, was
calculated for each structure, as follows:
ΔV %ð Þ ¼ Vauto  Vref
Vref
 100
Also the difference between manually corrected auto-
matic volume (VAM, VMM, VVM, for ABAS, MIM and
VElocityAI respectively) and the Vref was calculated.
Since its introduction, DICE similarity coefficient
(DSC) index [13] has been widely used in the evaluation
of deformable image registration results. The DSC index
is defined as
DSC ¼ 2  Vref \ Vauto
 
Vref þ Vauto
Vref were compared to automatically contoured ROIs
(or manually corrected after automatic generation ROIs).
DSC values range from 0 to 1, and are identical to 1 if
automatic and manual volumes were equal with a
complete intersection.
For all the software solutions evaluated, the sensitivity
index (Se) of contours was computed as:
Se ¼ Vref \ Vauto
Vref
The sensitivity reflects the probability that the auto-
matic contours (before or after the manual corrections)
match the reference contour and some authors renamed







PROSTATE 1.18.37 (0.09.23) ABAS 0.14.51 (0
MIM 0.02.34 (0
VELOCITY AI 0.08.23 (0
HEAD & NECK 2.43.12 (0.48.21) ABAS 0.10.58 (0
MIM 0.03.46 (0
VELOCITY AI 0.06.21 (0
MESOTHELIOMA 1.21.02 (0.05.00) ABAS 0.08.32 (0
MIM 0.02.35 (0
VELOCITY AI 0.06.47 (0
- For manual corrections time:
"*" = vs. Manual contour from scratch: p<0.05.
"#" = vs. Manual correction from ABAS: p<0.05.
"°" = vs. Manual correction from MIM: p<0.05.
"+" = vs. Manual correction from VelocityAI: p<0.05.
- For automatic+corrections:
"*" = vs. Manual contour from scratch: p<0.05.
"%" = vs. ABAS+ Manual correction from ABAS: p<0.05.
"}" = vs. MIM + Manual correction from MIM: p<0.05.
"=" = vs. Velocity AI + Manual correction from VelocityAI: p<0.05.We defined, as a surrogate of the specificity, the inclu-
siveness index (IncI):
IncI ¼ Vref \ Vauto
Vauto
The inclusiveness index reflects the inclusion of Vauto
within Vref , i.e. the probability that a voxel of the Vauto is
really a voxel of the Vref .
To help the reader get an idea of some parameter
trends, a modified Receiver Operating Characteristic
(mROC) analysis was done by plotting the sensitivity vs.
(1 _ IncI) for some delineated structure. The best pos-
sible result was expected to yield a point in the upper
left corner or coordinate (0, 1) of the ROC space, repre-
senting 100% sensitivity (all voxels are true positive) and
100% of inclusion (surrogate of specificity, i.e. no false
positive voxel is present).
As a general measure for the location of the structures,
for each patient and for each structure (manually defined
from scratch (i.e. reference structure), automatically gen-
erated and manually corrected after automatic gener-
ation) mass centre is calculated and the distance in the
three coordinates was evaluated:
Δx ¼ xauto  xref
 ;Δy ¼ yauto  yref
 ;Δz
¼ zauto  zref
 
As reported in Figure 1, in order to evaluate these
parameters in a systematic and consistent way, all
DICOM images and structures were exported to VOD-
CA4rt (MSS GmbH, Hagendorn, Switzerland) version
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.02.21) 1.09.15 (0.13.49) * ° + * } =
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Table 2 Mean values and standard deviations of parameters that evaluate the contours generated by the three
software, before and after the manual correction, for each organ of the prostate patients
AA MA VA AM MM VM p value
CTV1
DSC, (SD) 0.86 (0.08) 0.79 (0.05) 0.76 (0.14) 0.88 (0.09) 0.81 (0.04) 0.82 (0.02)
Sensitivity, (SD) 0.82 (0.11) 0.72 (0.11) 0.70 (0.20) 0.85 (0.11) 0.76 (0.09) 0.82 (0.07)
IncI, (SD) 0.92 (0.05) 0.89 (0.07) 0.85 (0.06) 0.91 (0.06) 0.88 (0.03) 0.84 (0.07) *
ΔV (%), (SD) −11.48 (7.83) −17.83 (17.60) −17.70 (23.61) −7.73 (6.32) −13.15 (12.11) −1.30 (15.18) °
Δx (mm), (SD) 0.45 (0.33) 0.35 (0.24) 0.38 (0.52) 0.35 (0.24) 0.55 (0.40) 0.85 (0.58)
Δy (mm), (SD) 0.60 (0.64) 0.93 (0.56) 0.68 (0.56) 1.03 (1.01) 0.83 (0.50) 0.88 (0.90)
Δz (mm), (SD) 1.25 (1.44) 3.18 (2.39) 1.88 (1.25) 1.28 (1.02) 2.23 (1.19) 2.20 (0.60)
CTV2
DSC, (SD) 0.77 (0.06) 0.86 (0.01) 0.83 (0.02) 0.87 (0.08) 0.87 (0.01) 0.84 (0.01) * ° =
Sensitivity, (SD) 0.67 (0.12) 0.87 (0.02) 0.84 (0.03) 0.86 (0.09) 0.87 (0.03) 0.85 (0.03) * ° =
IncI, (SD) 0.93 (0.06) 0.85 (0.02) 0.82 (0.04) 0.88 (0.08) 0.86 (0.03) 0.84 (0.02) * #
ΔV (%), (SD) −27.46 (17.74) 2.54 (4.98) 2.78 (8.47) −1.44 (8.11) 1.88 (7.6) 2.12 (6.31) * #
Δx (mm), (SD) 1.63 (1.37) 0.45 (0.41) 0.35 (0.47) 0.98 (1.13) 0.48 (0.41) 0.58 (0.22)
Δy (mm), (SD) 3.54 (1.28) 2.58 (0.92) 2.55 (1.30) 2.23 (2.62) 2.85 (0.93) 2.68 (1.03)
Δz (mm), (SD) 1.28 (1.79) 1.28 (1.79) 1.90 (1.62) 1.58 (1.90) 2.23 (1.85) 1.90 (1.63)
Rectum
DSC, (SD) 0.77 (0.07) 0.75 (0.09) 0.75 (0.04) 0.90 (0.07) 0.87 (0.05) 0.86 (0.05)
Sensitivity, (SD) 0.88 (0.06) 0.70 (0.17) 0.72 (0.13) 0.92 (0.08) 0.89 (0.05) 0.87 (0.07) * # ^
IncI , (SD) 0.69 (0.11) 0.84 (0.06) 0.79 (0.08) 0.88 (0.07) 0.86 (0.09) 0.86 (0.09)
ΔV (%), (SD) 30.2 (24.30) −15.38 (24.1) −7.06 (23.65) 4.7 (10.10) 5.2 (13.88) 2.34 (16.64) * °
Δx (mm), (SD) 2.00 (1.78) 2.14 (1.46) 3.36 (1.70) 1.30 (2.11) 0.720 (0.71) 1.92 (1.70)
Δy (mm), (SD) 2.74 (1.81) 1.36 (0.85) 1.50 (1.71) 1.44 (1.15) 0.90 (0.30) 1.16 (0.76)
Δz (mm), (SD) 6.54 (5.33) 6.02 (5.25) 6.04 (4.16) 3.78 (4.05) 6.8 (3.71) 7.28 (5.11) ^
Bladder
DSC, (SD) 0.93 (0.03) 0.88 (0.07) 0.72 (0.15) 0.95 (0.04) 0.93 (0.02) 0.93 (0.02) # °
Sensitivity, (SD) 0.93 (0.03) 0.88 (0.12) 0.67 (0.25) 0.96 (0.03) 0.96 (0.03) 0.93 (0.05) =
IncI, (SD) 0.92 (0.06) 0.89 (0.04) 0.89 (0.13) 0.94 (0.04) 0.91 (0.03) 0.93 (0.05) +
ΔV (%), (SD) 1.88 (8.29) −1.70 (14.87) −20.24 (43.21) 2.40 (3.90) 6.12 (5.89) 0.20 (8.79) =
Δx (mm), (SD) 1.10 (0.16) 0.46 (0.46) 0.90 (0.67) 0.66 (0.53) 0.46 (0.46) 0.86 (1.01)
Δy (mm), (SD) 1.32 (1.53) 3.42 (3.98) 3.44 (4.06) 0.52 (0.56) 0.72 (0.57) 0.76 (0.34)
Δz (mm), (SD) 1.80 (0.66) 2.02 (1.12) 5.02 (2.92) 2.02 (2.28) 1.80 (1.19) 2.02 (1.43) ^
Bowel
DSC, (SD) 0.83 (0.10) 0.85 (0.09) 0.88 (0.03) 0.89 (0.12) 0.92 (0.02) 0.87 (0.09) =
Sensitivity, (SD) 0.79 (0.15) 0.82 (0.14) 0.88 (0.03) 0.88 (0.18) 0.94 (0.02) 0.84 (0.15) =
IncI, (SD) 0.89 (0.08) 0.90 (0.04) 0.88 (0.05) 0.91 (0.05) 0.91 (0.03) 0.91 (0.01)
ΔV (%), (SD) −10.78 (17.74) −9.12 (14.13) −0.10 (6.50) −3.38 (18.54) 2.36 (2.98) −7.82 (15.27)
Δx (mm), (SD) 3.44 (2.63) 2.58 (1.84) 3.32 (3.06) 2.16 (1.79) 2.98 (1.40) 3.46 (3.36)
Δy (mm), (SD) 8.42 (3.68) 6.88 (3.90) 5.34 (3.72) 4.20 (5.56) 7.48 (3.82) 4.78 (5.87)
Δz (mm), (SD) 9.78 (10.21) 9.78 (12.15) 6.28 (4.43) 6.02 (11.39) 0.26 (0.58) 5.00 (11.18)
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Table 2 Mean values and standard deviations of parameters that evaluate the contours generated by the three
software, before and after the manual correction, for each organ of the prostate patients (Continued)
Femoral head right
DSC, (SD) 0.94 (0.04) 0.94 (0.02) 0.92 (0.03) 0.94 (0.04) 0.94 (0.01) 0.93 (0.02) # ° =
Sensitivity, (SD) 0.94 (0.05) 0.96 (0.02) 0.94 (0.03) 0.94 (0.05) 0.95 (0.02) 0.95 (0.03) °
IncI , (SD) 0.94 (0.04) 0.93 (0.03) 0.90 (0.04) 0.95 (0.04) 0.93 (0.03) 0.91 (0.03) * # ° + ^ =
ΔV (%), (SD) 0.12 (4.98) 2.92 (4.63) 4.82 (4.53) −0.18 (4.92) 2.76 (4.98) 4.22 (5.08) °
Δx (mm), (SD) 0.16 (0.36) 0.36 (0.21) 0.46 (0.49) 0.16 (0.36) 0.36 (0.21) 0.64 (0.31)
Δy (mm), (SD) 0.18 (0.25) 0.36 (0.38) 0.74 (0.51) 0.26 (0.24) 0.36 (0.38) 0.92 (0.67)
Δz (mm), (SD) 1.76 (1.11) 1.76 (1.70) 1.76 (2.09) 1.78 (1.43) 2.02 (0.66) 2.04 (1.11)
Femoral head left
DSC, (SD) 0.94 (0.04) 0.94 (0.03) 0.92 (0.02) 0.94 (0.04) 0.94 (0.02) 0.92 (0.03) * # ^
Sensitivity, (SD) 0.95 (0.04) 0.96 (0.02) 0.94 (0.02) 0.95 (0.04) 0.96 (0.02) 0.95 (0.03) ° =
IncI , (SD) 0.93 (0.05) 0.92 (0.05) 0.90 (0.04) 0.94 (0.05) 0.92 (0.04) 0.90 (0.05) # ^
ΔV (%), (SD) 2.30 (5.73) 4.92 (6.06) 5.42 (6.47) 1.24 (6.01) 4.94 (5.70) 4.94 (7.35) * # + ^
Δx (mm), (SD) 0.62 (0.91) 0.68 (0.67) 0.66 (0.49) 0.62 (0.91) 0.68 (0.67) 0.76 (0.44)
Δy (mm), (SD) 0.16 (0.36) 0.36 (0.38) 0.64 (0.31) 0.16 (0.36) 0.36 (0.38) 0.76 (0.51)
Δz (mm), (SD) 3.28 (1.91) 2.26 (1.85) 2.02 (1.92) 2.02 (1.43) 1.52 (1.04) 2.30 (1.37)
For automatic segmentation: *AA vs. MA: p<0.043, #AA vs. VA: p<0.043, °MA vs. VA: p<0.043.
For automatic segmentation+ manual correction: +AM vs. MM: p<0.043, ^AM vs. VM: p<0.043, =MM vs. VM: p<0.043.
Abbreviations: CTV = Clinical target volume; SD = Standard deviation, DSC = DICE similarity coefficient, IncI = inclusiveness index, AA = Abas Automatic, MA = MiM
Automatic, VA = Velocity Automatic, AM = Abas Manual Correction, MM = MiM Manual Correction, VM = Velocity Manual Correction.
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described above.
A non-parametric Wilcoxon signed rank test was used
to determine whether or not the observed differences
were statistically significant. The Holm-Bonferroni cor-
rection was considered as well.
Results
Time/speed evaluation
Table 1 shows the average time needed for manual con-
touring, the software time for AC and correction time
for the VOIs on rCT for each anatomical site. The differ-
ences in AC time between A, M and V are always statis-
tically significant.
After comparing the sum of the average duration of
automatic +manual correction for each site and software
with the total time needed to get the Vref, we can con-
clude the following: 1) for prostate patients, MIM was
the software that obtained the most gain in time
(55 min), while the average gain was 31 min and 41 min
with ABAS and VelocityAI respectively; 2) for the H&N
site, ABAS was the most time saving software with an
average gain of 1 hour and 23 min; MIM can save 1 hour
and 4 min, and VelocityAI 45 min; 3) for the mesotheli-
oma cases, the average obtained gain was 22 min with
both ABAS and MIM, and 15 min with Velocity. For all
sites, the time gain for all three software solutions, com-
pared to manual contouring from scratch, is statistically
significant. In Table 1 we also reported the time neededfor manual correction, aside from the time needed for
the automatic contouring as the reader may be inter-
ested in the ‘physician time’ saved, independently from
the time the software takes to generate the automatic
contours.
Contour evaluation
Regarding the DSC index for structures located in the
pelvis, an important example is given by the rectum.
Table 2 shows how similar this index is for all three
software solutions, with regards to the AC (AA= 0.77,
MA=0.75, VA= 0.75). However, it is quite far from the
value 1; this means that all three VOIs, which were
obtained automatically, are not qualitatively close to the
Vref. After manual correction of the automatic contours,
the DSC improved for all the software solutions but the
values of this index still remained ≤ 0.9. For this organ
we found a ΔV from about +30% to −15% for AA and
MA respectively that was reduced to about 5% after the
manual correction. The Δz values for rectum (before
and after manual correction) underlined the difficulty in
contouring the cranio-caudal limits of this structure.
The three software solutions tended to give us CTV1
and bowel volumes smaller than the Vref. VelocityAI
had a lower sensitivity index, also after manual correc-
tion, compared to the other two softwares.
Regarding the H&N cases (Table 3), there were no sta-
tistically significant differences between the three soft-
ware solutions for the CTV2, larynx, and superior part
Table 3 Mean values and standard deviations of parameters that evaluate the contours generated by the three
software, before and after the manual correction, for each organ of the head and neck
AA MA VA AM MM VM p value
CTV1
DSC, (SD) 0.68 (0.19) 0.67 (0.17) 0.66 (0.18) 0.72 (0.15) 0.76 (0.11) 0.71 (0.09) #
Sensitivity, (SD) 0.73 (0.23) 0.76 (0.19) 0.74 (0.22) 0.79 (0.18) 0.85 (0.10) 0.81 (0.16)
IncI, (SD) 0.64 (0.17) 0.61 (0.18) 0.60 (0.17) 0.67 (0.13) 0.69 (0.13) 0.65 (0.09) * #
ΔV (%), (SD) 14.10 (25.99) 25.92 (21.18) 23.28 (28.44) 17.72 (22.19) 24.94 (26.01) 27.40 (32.49)
Δx (mm), (SD) 2.62 (2.02) 2.92 (1.76) 2.44 (1.58) 2.12 (1.45) 2.70 (1.03) 2.88 (2.42)
Δy (mm), (SD) 2.58 (2.70) 2.66 (2.72) 2.86 (2.37) 2.60 (2.47) 2.74 (2.47) 5.30 (3.32)
Δz (mm), (SD) 5.40 (7.98) 5.70 (5.65) 5.10 (5.77) 5.40 (7.98) 3.60 (5.67) 4.80 (5.02)
CTV2
DSC, (SD) 0.84 (0.03) 0.83 (0.03) 0.81 (0.02) 0.85 (0.03) 0.84 (0.03) 0.82 (0.03)
Sensitivity, (SD) 0.85 (0.04) 0.86 (0.05) 0.85 (0.05) 0.86 (0.04) 0.88 (0.04) 0.86 (0.04)
IncI, (SD) 0.83 (0.06) 0.81 (0.06) 0.78 (0.05) 0.83 (0.06) 0.81 (0.06) 0.78 (0.06)
ΔV (%), (SD) 3.50 (11.31) 7.40 (13.33) 10.00 (12.34) 4.45 (10.20) 8.38 (11.57) 10.68 (12.51)
Δx (mm), (SD) 2.95 (2.30) 2.85 (1.85) 3.08 (1.81) 2.48 (2.56) 2.95 (1.80) 3.38 (1.37)
Δy (mm), (SD) 2.38 (0.69) 3.73 (2.50) 2.53 (1.94) 2.23 (0.95) 3.60 (2.54) 2.90 (1.51)
Δz (mm), (SD) 1.50 (1.23) 1.50 (2.12) 1.88 (2.25) 1.50 (1.23) 1.88 (1.44) 2.63 (1.44)
Larynx
DSC, (SD) 0.86 (0.04) 0.87 (0.01) 0.82 (0.04) 0.90 (0.03) 0.89 (0.02) 0.86 (0.05)
Sensitivity, (SD) 0.87 (0.06) 0.88 (0.03) 0.85 (0.06) 0.92 (0.04) 0.93 (0.01) 0.91 (0.02)
IncI, (SD) 0.86 (0.03) 0.85 (0.03) 0.80 (0.05) 0.87 (0.02) 0.85 (0.02) 0.82 (0.08)
ΔV (%), (SD) 1.43 (5.92) 3.85 (6.75) 5.83 (9.59) 5.15 (3.37) 8.55 (1.93) 11.20 (11.32)
Δx (mm), (SD) 0.65 (0.51) 0.38 (0.48) 0.88 (0.48) 0.90 (0.52) 0.53 (0.61) 0.50 (0.00)
Δy (mm), (SD) 0.38 (0.25) 0.75 (0.65) 0.40 (0.80) 0.38 (0.25) 0.50 (0.58) 0.90 (0.52)
Δz (mm), (SD) 5.63 (3.75) 9.75 (5.81) 3.75 (4.50) 0.75 (0.87) 1.50 (1.23) 0.75 (1.50)
Sup. Pharynx
DSC, (SD) 0.36 (0.22) 0.35 (0.12) 0.33 (0.13) 0.57 (0.05) 0.50 (0.14) 0.52 (0.11)
Sensitivity, (SD) 0.49 (0.38) 0.51 (0.35) 0.47 (0.32) 0.74 (0.10) 0.80 (0.11) 0.76 (0.11)
IncI, (SD) 0.42 (0.14) 0.42 (0.26) 0.40 (0.23) 0.49 (0.13) 0.40 (0.20) 0.42 (0.19)
ΔV (%), (SD) 27.70 (90.39) 67.50 (125.10) 57.25 (112.28) 61.63 (48.64) 146.60 (134.73) 107.58 (96.01)
Δx (mm), (SD) 1.18 (1.41) 1.43 (1.27) 1.73 (2.45) 0.98 (0.95) 0.75 (0.50) 1.03 (0.82)
Δy (mm), (SD) 1.88 (1.38) 1.90 (1.04) 3.23 (3.78) 1.13 (0.90) 1.48 (1.63) 1.88 (1.74)
Δz (mm), (SD) 6.00 (3.24) 6.75 (3.12) 4.88 (3.75) 3.00 (1.73) 4.50 (2.12) 3.38 (3.09)
Mid. Pharynx
DSC, (SD) 0.57 (0.10) 0.56 (0.13) 0.43 (0.19) 0.61 (0.09) 0.60 (0.12) 0.62 (0.12)
Sensitivity, (SD) 0.52 (0.12) 0.57 (0.17) 0.44 (0.19) 0.59 (0.12) 0.68 (0.15) 0.64 (0.13) °
IncI, (SD) 0.65 (0.13) 0.56 (0.12) 0.44 (0.21) 0.64 (0.10) 0.55 (0.13) 0.61 (0.11) * #
ΔV (%), (SD) −18.94 (18.43) 4.62 (27.73) 4.12 (37.64) −7.48 (16.77) 27.38 (34.84) 4.66 (9.21) * +
Δx (mm), (SD) 0.60 (0.82) 0.80 (0.45) 1.20 (1.11) 0.90 (0.82) 0.80 (0.45) 0.70 (0.57)
Δy (mm), (SD) 3.32 2.64() 2.78 (1.08) 2.64 (2.256) 3.02 (2.78) 2.76 (2.32) 1.68 (1.29)
Δz (mm), (SD) 4.20 (4.55) 3.90 (4.70) 4.80 (5.13) 4.20 (4.42) 5.40 (4.81) 5.10 (5.37)
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Table 3 Mean values and standard deviations of parameters that evaluate the contours generated by the three
software, before and after the manual correction, for each organ of the head and neck (Continued)
Inf. Pharynx
DSC, (SD) 0.65 (0.07) 0.66 (0.05) 0.63 (0.07) 0.71 (0.04) 0.72 (0.03) 0.72 (0.04)
Sensitivity, (SD) 0.59 (0.08) 0.65 (0.08) 0.60 (0.09) 0.67 (0.04) 0.72 (0.10) 0.73 (0.07) *
IncI, (SD) 0.75 (0.11) 0.69 (0.07) 0.66 (0.09) 0.75 (0.10) 0.72 (0.05) 0.72 (0.09) # ^
ΔV (%), (SD) −20.04 (15.57) −5.58 (17.12) −7.46 (16.01) −9.96 (14.02) 1.62 (19.64) 3.22 (18.60) * #
Δx (mm), (SD) 1.12 (0.44) 0.72 (0.47) 0.90 (0.65) 0.60 (0.55) 0.50 (0.50) 0.70 (0.48)
Δy (mm), (SD) 2.06 (2.28) 1.62 (1.63) 1.38 (1.43) 1.90 (2.12) 1.52 (0.61) 1.28 (2.07)
Δz (mm), (SD) 3.90 (3.29) 2.70 (1.26) 3.00 (3.82) 4.50 (3.52) 4.20 (2.47) 2.70 (3.25)
Thyroid
DSC, (SD) 0.73 (0.11) 0.77 (0.06) 0.73 (0.07) 0.81 (0.05) 0.82 (0.06) 0.82 (0.05) ^
Sensitivity, (SD) 0.79 (0.15) 0.81 (0.10) 0.79 (0.08) 0.86 (0.08) 0.84 (0.05) 0.84 (0.04)
IncI, (SD) 0.69 (0.11) 0.75 (0.10) 0.70 (0.11) 0.78 (0.10) 0.81 (0.10) 0.80 (0.07) °
ΔV (%), (SD) 14.86 (23.01) 10.34 (28.54) 15.70 (26.54) 14.00 (25.25) 5.72 (17.65) 5.98 (9.27) °
Δx (mm), (SD) 0.98 (0.82) 1.26 (1.51) 1.48 (1.37) 0.50 (0.00) 0.70 (0.98) 1.56 (1.93)
Δy (mm), (SD) 1.18 (1.06) 0.98 (0.90) 1.68 (2.12) 0.70 (0.45) 0.40 (0.42) 0.60 (0.55)
Δz (mm), (SD) 3.00 (2.37) 2.10 (2.28) 1.50 (1.50) 2.70 (2.47) 1.20 (1.96) 2.10 (1.34)
Masticator space right
DSC, (SD) 0.80 (0.04) 0.82 (0.03) 0.80 (0.03) 0.85 (0.02) 0.84 (0.04) 0.84 (0.02) °
Sensitivity, (SD) 0.79 (0.07) 0.84 (0.03) 0.80 (0.06) 0.83 (0.07) 0.91 (0.02) 0.86 (0.03) ° + =
IncI, (SD) 0.84 (0.10) 0.80 (0.03) 0.80 (0.02) 0.86 (0.05) 0.79 (0.07) 0.82 (0.02) + ^
ΔV (%), (SD) −3.52 (21.72) 4.74 (3.43) −0.62 (6.99) −3.16 (12.28) 16.28 (12.24) 5.14 (2.48) ° =
Δx (mm), (SD) 0.82 (0.58) 1.00 (0.5) 0.82 (0.58) 0.50 (0.71) 0.90 (0.82) 0.82 (0.30)
Δy (mm), (SD) 1.12 (0.69) 1.20 (0.99) 1.20 (1.29) 1.02 (0.36) 1.78 (1.85) 1.30 (1.19)
Δz (mm), (SD) 3.30 (1.64) 4.80 (5.13) 5.40 (4.70) 2.70 (0.67) 3.00 (3.52) 2.70 (1.64)
Masticator Space left
DSC, (SD) 0.79 (0.05) 0.81 (0.05) 0.77 (0.05) 0.86 (0.02) 0.86 (0.03) 0.85 (0.02) * # °
Sensitivity, (SD) 0.72 (0.08) 0.79 (0.08) 0.73 (0.09) 0.82 (0.05) 0.89 (0.03) 0.86 (0.04) * ° + ^
IncI, (SD) 0.89 (0.05) 0.85 (0.01) 0.82 (0.01) 0.90 (0.02) 0.83 (0.07) 0.84 (0.03) ° + ^
ΔV (%), (SD) −18.64 (12.32) −7.02 (10.16) −10.58 (12.18) −8.30 (5.83) 8.26 (10.51) 3.00 (5.82) ° + ^
Δx (mm), (SD) 0.84 (1.34) 1.02 (0.65) 1.02 (0.82) 1.040 (0.96) 0.92 (0.58) 0.62 (0.69)
Δy (mm), (SD) 2.26 (1.85) 1.76 (1.27) 2.12 (0.80) 1.820 (1.08) 2.52 (2.76) 1.94 (1.37)
Δz (mm), (SD) 3.00 (2.60) 6.00 (5.09) 6.00 (5.91) 2.40 (0.82) 3.00 (4.37) 2.40 (1.34)
Mandible
DSC, (SD) 0.89 (0.02) 0.86 (0.02) 0.84 (0.02) 0.90 (0.02) 0.89 (0.02) 0.89 (0.02) *
Sensitivity, (SD) 0.87 (0.05) 0.86 (0.04) 0.82 (0.04) 0.88 (0.04) 0.92 (0.03) 0.92 (0.03) + ^
IncI, (SD) 0.92 (0.02) 0.86 (0.05) 0.86 (0.06) 0.92 (0.02) 0.86 (0.05) 0.87 (0.05) * # + ^
ΔV (%), (SD) −4.76 (7.12) −0.48 (9.51) −3.60 (12.00) −3.88 (6.02) 7.06 (9.05) 7.02 (8.78)
Δx (mm), (SD) 0.30 (0.27) 0.60 (0.42) 0.50 (0.35) 0.30 (0.27) 0.70 (0.57) 0.30 (0.27)
Δy (mm), (SD) 0.30 (0.27) 0.40 (0.22) 0.50 (0.35) 0.30 (0.27) 0.30 (0.27) 0.20 (0.27)
Δz (mm), (SD) 0.60 (0.82) 0.30 (0.67) 1.20 (1.26) 0.90 (0.82) 0.60 (0.82) 0.60 (0.82)
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Table 3 Mean values and standard deviations of parameters that evaluate the contours generated by the three
software, before and after the manual correction, for each organ of the head and neck (Continued)
Spinal cord
DSC, (SD) 0.70 (0.10) 0.81 (0.05) 0.78 (0.06) 0.84 (0.02) 0.87 (0.01) 0.86 (0.01) *
Sensitivity, (SD) 0.60 (0.14) 0.78 (0.10) 0.75 (0.08) 0.78 (0.05) 0.87 (0.03) 0.88 (0.04) * #
IncI, (SD) 0.89 (0.07) 0.86 (0.07) 0.83 (0.08) 0.91 (0.05) 0.87 (0.02) 0.84 (0.03)
ΔV (%), (SD) −32.46 (19.30) −9.00 (16.93) −8.40 (14.92) −13.18 (9.26) 0.66 (4.55) 5.52 (8.34) * # + ^
Δx (mm), (SD) 0.80 (0.45) 0.60 (0.22) 0.92 (0.66) 1.00 (0.80) 0.90 (0.42) 0.30 (0.27)
Δy (mm), (SD) 3.62 (6.98) 4.88 (7.20) 2.78 (3.96) 0.92 (0.43) 0.32 (0.72) 0.62 (0.59)
Δz (mm), (SD) 7.80 (11.74) 7.20 (12.79) 6.00 (10.92) 0.60 (0.82) 0.30 (0.67) 0.00 (0.00)
Parotid gland right
DSC, (SD) 0.78 (0.08) 0.79 (0.07) 0.73 (0.08) 0.80 (0.06) 0.82 (0.05) 0.80 (0.05) # ° =
Sensitivity, (SD) 0.79 (0.13) 0.82 (0.12) 0.79 (0.16) 0.82 (0.12) 0.86 (0.10) 0.84 (0.10) +
IncI, (SD) 0.80 (0.11) 0.77 (0.09) 0.71 (0.08) 0.80 (0.09) 0.79 (0.07) 0.79 (0.10) #
ΔV (%), (SD) −1.06 (21.92) 8.96 (21.67) 13.02 (29.54) 4.40 (22.94) 10.40 (18.23) 9.14 (23.61) *
Δx (mm), (SD) 1.50 (1.00) 1.62 (1.24) 2.02 (1.06) 1.96 (1.79) 1.62 (1.24) 1.94 (1.19)
Δy (mm), (SD) 6.46 (7.06) 5.64 (5.66) 6.58 (6.25) 6.4 (7.11) 4.32 (6.34) 5.76 (7.04)
Δz (mm), (SD) 2.40 (0.82) 2.40 (0.82) 3.60 (2.51) 1.80 (1.26) 1.50 (1.06) 1.20 (1.64)
Parotid gland left
DSC, (SD) 0.79 (0.07) 0.78 (0.08) 0.73 (0.04) 0.80 (0.07) 0.81 (0.06) 0.81 (0.05) °
Sensitivity, (SD) 0.77 (0.11) 0.79 (0.11) 0.77 (0.05) 0.79 (0.11) 0.83 (0.09) 0.85 (0.07) ^
IncI, (SD) 0.82 (0.07) 0.77 (0.11) 0.69 (0.04) 0.82 (0.09) 0.80 (0.11) 0.78 (0.08) #
ΔV (%), (SD) −5.84 (17.41) 4.44 (20.36) 12.96 (4.75) −1.88 (21.29) 6.54 (21.64) 9.78 (14.61) *
Δx (mm), (SD) 2.00 (1.46) 2.46 (1.23) 2.12 (1.43) 2.12 (1.62) 2.08 (1.46) 3.08 (1.75) ^
Δy (mm), (SD) 1.68 (2.21) 2.60 (1.37) 2.12 (1.76) 1.38 (1.60) 0.78 (1.21) 1.38 (2.00)
Δz (mm), (SD) 3.60 (2.73) 3.30 (2.68) 4.50 (1.50) 2.70 (1.96) 3.60 (2.73) 2.70 (2.23)
Cochlea right
DSC, (SD) 0.63 (0.13) 0.63 (0.17) 0.46 (0.16) 0.80 (0.03) 0.77 (0.10) 0.69 (0.07) # ° ^
Sensitivity, (SD) 0.59 (0.17) 0.68 (0.24) 0.42 (0.13) 0.77 (0.09) 0.84 (0.11) 0.80 (0.10) # °
IncI, (SD) 0.71 (0.17) 0.64 (0.23) 0.55 (0.25) 0.88 (0.09) 0.72 (0.07) 0.64 (0.14) # + ^
ΔV (%), (SD) −5.28 (6.84) 16.94 (54.41) −15.74 (23.04) −7.36 (17.40) 17.9 (21.82) 33.98 (49.56) +
Δx (mm), (SD) 0.90 (0.42) 0.72 (0.47) 1.28 (1.11) 0.42 (0.24) 0.62 (0.69) 0.72 (0.88)
Δy (mm), (SD) 1.38 (1.77) 1.38 (1.20) 1.60 (1.90) 0.40 (0.42) 0.30 (0.27) 0.72 (0.30)
Δz (mm), (SD) 0.50 (0.71) 0.90 (0.82) 2.40 (2.01) 0.40 (0.65) 0.30 (0.67) 0.90 (0.82)
Cochlea left
DSC, (SD) 0.52 (0.16) 0.69 (0.10) 0.59 (0.07) 0.78 (0.07) 0.78 (0.04) 0.72 (0.07) °
Sensitivity, (SD) 0.45 (0.22) 0.69 (0.13) 0.58 (0.07) 0.69 (0.09) 0.81 (0.05) 0.75 (0.08) * +
IncI, (SD) 0.87 (0.10) 0.70 (0.15) 0.63 (0.13) 0.92 (0.05) 0.76 (0.09) 0.72 (0.16) * # + ^
ΔV (%), (SD) −51.04 (29.55) 6.06 (30.04) −5.40 (13.70) −23.32 (10.44) 10.24 (12.62) 11.50 (34.88) * + ^
Δx (mm), (SD) 1.00 (0.50) 0.60 (0.42) 1.00 (0.71) 0.30 (0.27) 0.40 (0.22) 0.50 (0.50)
Δy (mm), (SD) 0.40 (0.42) 0.40 (0.42) 0.90 (0.55) 0.60 (0.55) 0.20 (0.45) 1.00 (0.50) =
Δz (mm), (SD) 0.90 (0.82) 1.00 (1.28) 1.00 (1.28) 0.30 (0.67) 1.20 (1.26) 0.40 (0.65)
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Table 3 Mean values and standard deviations of parameters that evaluate the contours generated by the three
software, before and after the manual correction, for each organ of the head and neck (Continued)
Brain stem
DSC, (SD) 0.80 (0.07) 0.81 (0.11) 0.77 (0.15) 0.88 (0.02) 0.88 (0.03) 0.89 (0.03)
Sensitivity, (SD) 0.74 (0.09) 0.76 (0.17) 0.73 (0.22) 0.86 (0.04) 0.86 (0.08) 0.89 (0.03)
IncI, (SD) 0.89 (0.06) 0.89 (0.03) 0.85 (0.03) 0.90 (0.02) 0.90 (0.03) 0.88 (0.04)
ΔV (%), (SD) −17.50 (8.23) −14.36 (19.96) −13.68 (26.28) −4.54 (6.22) −4.00 (10.88) 1.44 (1.75) ^
Δx (mm), (SD) 0.70 (0.57) 1.32 (0.78) 1.12 (0.69) 0.60 (0.22) 0.92 (0.86) 1.04 (1.02)
Δy (mm), (SD) 1.40 (0.82) 1.76 (0.80) 1.88 (0.74) 0.68 (0.82) 0.90 (1.34) 1.10 (0.67)
Δz (mm), (SD) 2.40 (3.29) 3.00 (3.82) 4.20 (4.67) 0.90 (0.82) 0.90 (1.34) 0.30 ()
Esophagus
DSC, (SD) 0.63 (0.10) 0.65 (0.15) 0.64 (0.13) 0.83 (0.05) 0.84 (0.06) 0.83 (0.06)
Sensitivity, (SD) 0.57 (0.15) 0.57 (0.19) 0.63 (0.17) 0.85 (0.06) 0.87 (0.04) 0.88 (0.02)
IncI, (SD) 0.76 (0.12) 0.79 (0.09) 0.67 (0.11) 0.82 (0.10) 0.82 (0.11) 0.79 (0.10) °
ΔV (%), (SD) −21.68 (29.94) −27.04 (26.22) −5.92 (23.75) 5.62 (18.34) 8.26 (18.26) 12.04 (12.37)
Δx (mm), (SD) 1.12 (0.42) 1.38 (1.05) 1.54 (0.86) 0.60 (0.65) 0.80 (0.57) 1.00 (0.79)
Δy (mm), (SD) 3.84 (5.83) 4.54 (6.48) 3.66 (3.77) 0.82 (0.84) 1.12 (0.76) 0.72 (0.79)
Δz (mm), (SD) 7.80 (11.64) 7.50 (12.68) 6.60 (10.64) 1.50 (1.06) 1.20 (1.26) 1.20 (1.26)
For automatic segmentation: *AA vs. MA: p<0.043, #AA vs. VA: p<0.043, °MA vs. VA: p<0.043.
For automatic segmentation+ manual correction: +AM vs. MM: p<0.043, ^AM vs. VM: p<0.043, =MM vs. VM: p<0.043.
Abbreviations: CTV = Clinical target volume; SD = Standard deviation, DSC = DICE similarity coefficient, IncI = inclusiveness index, AA = Abas Automatic, MA = MiM
Automatic, VA = Velocity Automatic, AM = Abas Manual Correction, MM = MiM Manual Correction, VM = Velocity Manual Correction.
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showed a higher inclusiveness index whereas MIM
showed a higher sensitivity. From the ΔV parameter ana-
lysis, we found that ABAS tended to underestimate the
volume of the VOI, while MIM and VelocityAI tended
to overestimate it.
Finally, in the mesothelioma cases (Table 4), the sensi-
tivity index was usually higher for ABAS, before manual
correction, and for VelocityAI after manual correction.
Regarding the IncI index statistically significant differ-
ences are present in both automatic and manually cor-
rected contours: MIM usually resulted to be the best
software in both cases. For the automatic contours,
the ΔV ranged from about +30% for the esophagus, to
−10% for the intestine; these differences usually
decreased after ACMC, but sometimes remained high
(i.e. CTV, esophagus, and spinal cord).
Figures 2, 3 and 4 show the mROC analysis of the per-
formance of automatic segmentation compared to man-
ual correction after automatic segmentation. The mROC
curves for the selected OARs exhibited the same behav-
iour: all the points improved with manual correction (i.e.
they moved to the upper left corner of the mROC
space), but under our clinical conditions some discrep-
ancies still remain compared to the reference structure.
Regarding the automatic re contouring of the tumor,
we can summarize that for prostate patients the DSC
index improved after manual correction, but it still
remained below 0.9; in H&N cases, the DSC indeximproved after manual correction for CTV1 (but still
remained below 0.8) and almost didn’t vary for CTV2.
In the mesothelioma patients, the DSC index improved,
for the three software solutions, from an average value
of 0.85 before manual correction to 0.9, with MIM per-
forming slightly better than the other two software
solutions.
Furthermore due to the low number of patients exam-
ined, applying the Holm-Bonferroni method, none of the
difference between the software solutions would have
been statistically significant. That is why we reported in
our Tables the p values obtained with the Wilcoxon test.
Discussion
The need to replan and adapt treatment for internal
anatomy variations due to tumor shrinkage and shape
deformation [1,3] has increased over the years in order
to make better use of highly conformal treatment tech-
niques. However, this modality is very time-consuming.
In order to reduce the commitment of medical staff in
targets and ROIs delineation and modification, systems
for the AC have been increasingly developed. The use of
atlas-based tools to delineate OARs for cancer sites in-
cluding H&N [11,14], breast [15], endometrium [16] and
prostate [17] have shown to reduce volume delineation
variability and the total time required to contour. In this
study, we compared three different commercial software
solutions for atlas-based autocontouring through a com-
parison with manual delineation of target and OAR in
Table 4 Mean values and standard deviations of parameters that evaluate the contours generated by the three
software, before and after the manual correction, for each organ of the mesothelioma patients
AA MA VA AM MM VM p value
CTV
DSC, (SD) 0.85 (0.02) 0.86 (0.02) 0.85 (0.02) 0.85 (0.02) 0.94 (0.04) 0.91 (0.02) + ^
Sensitivity. (SD) 0.92 (0.03) 0.90 (0.02) 0.91 (0.02) 0.92 (0.03) 0.93 (0.03) 0.94 (0.03) * ° ^
IncI. (SD) 0.79 (0.02) 0.82 (0.02) 0.80 (0.02) 0.80 (0.02) 0.95 (0.06) 0.87 (0.02) * ° + ^ =
ΔV (%). (SD) 15.54 (1.53) 9.26 (2.06) 13.48 (2.45) 14.90 (1.45) −1.78 (4.95) 8.10 (3.04) * ° + ^ =
Δx (mm). (SD) 3.42 (4.20) 3.42 (2.79) 4.10 (2.24) 4.20 (4.24) 0.98 (1.24) 3.40 (2.51) =
Δy (mm). (SD) 3.82 (3.60) 3.92 (3.61) 3.52 (3.90) 3.54 (3.69) 1.78 (1.56) 2.36 (1.51)
Δz (mm). (SD) 4.00 (4.87) 4.00 (4.87) 4.50 (4.80) 4.00 (3.35) 0.50 (1.12) 0.00 (0.00) ^
Contra lateral lung
DSC. (SD) 0.95 (0.03) 0.94 (0.03) 0.94 (0.02) 0.97 (0.01) 0.98 (0.01) 0.99 (0.01) ^ =
Sensitivity. (SD) 0.93 (0.05) 0.90 (0.06) 0.92 (0.04) 0.97 (0.01) 0.97 (0.01) 0.99 (0.01) ° ^ =
IncI. (SD) 0.97 (0.02) 0.99 (0.01) 0.96 (0.020) 0.97 (0.02) 0.98 (0.03) 0.99 (0.01) * °
ΔV (%). (SD) −4.66 (5.16) −8.68 (6.59) −4.16 (5.43) 0.14 (3.36) −1.24 (3.51) −0.52 (0.98) * °
Δx (mm). (SD) 0.70 (0.67) 0.40 (0.55) 0.88 (1.43) 1.48 (2.22) 0.60 (0.42) 0.00 (0.00)
Δy (mm). (SD) 2.46 (2.59) 2.46 (2.59) 2.24 (2.50) 1.30 (0.67) 0.90 (0.96) 0.00 (0.00) ^
Δz (mm). (SD) 7.50 (7.07) 7.50 (7.07) 10.00 (7.91) 1.88 (3.75) 1.88 (3.75) 0.00 (0.00)
Esophagus
DSC. (SD) 0.68 (0.08) 0.67 (0.08) 0.62 (0.03) 0.69 (0.08) 0.83 (0.12) 0.76 (0.02) # °
Sensitivity. (SD) 0.78 (0.08) 0.69 (0.10) 0.73 (0.09) 0.79 (0.08) 0.80 (0.13) 0.84 (0.07) * #
IncI. (SD) 0.61 (0.13) 0.67 (0.13) 0.54 (0.07) 0.62 (0.13) 0.86 (0.12) 0.70 (0.06) * ° + =
ΔV (%). (SD) 32.92 (31.51) 6.80 (25.74) 37.98 (28.67) 33.46 (32.52) −5.98 (11.80) 21.22 (17.13) * ° + =
Δx (mm). (SD) 3.82 (2.46) 2.36 (1.84) 2.92 (2.49) 3.34 (1.87) 1.30 (0.76) 1.40 (0.55) ^
Δy (mm). (SD) 2.74 (2.78) 2.54 (2.84) 2.26 (2.33) 2.74 (2.77) 1.18 (1.81) 2.16 (2.92)
Δz (mm). (SD) 7.50 (7.29) 8.00 (6.94) 7.00 (6.47) 7.50 (7.29) 5.00 (7.32) 5.50 (7.37) +
Heart
DSC. (SD) 0.88 (0.03) 0.87 (0.05) 0.88 (0.05) 0.90 (0.01) 0.94 (0.01) 0.95 (0.01) + ^
Sensitivity. (SD) 0.86 (0.09) 0.82 (0.10) 0.86 (0.10) 0.89 (0.06) 0.93 (0.03) 0.94 (0.02) * ° ^
IncI. (SD) 0.91 (0.04) 0.93 (0.04) 0.90 (0.03) 0.91 (0.05) 0.96 (0.04) 0.96 (0.02) * ^
ΔV (%). (SD) −4.48 (14.19) −11.40 (13.81) −4.58 (14.07) −1.50 (11.80) −2.30 (6.80) −2.02 (4.08) * °
Δx (mm). (SD) 1.26 (1.04) 1.18 (0.80) 1.20 (0.45) 1.38 (0.99) 0.80 (0.45) 1.58 (0.93)
Δy (mm). (SD) 1.78 (1.22) 1.58 (1.26) 1.76 (1.48) 1.86 (1.25) 1.08 (1.10) 1.28 (0.72)
Δz (mm). (SD) 2.50 (1.77) 3.50 (2.85) 3.50 (2.24) 3.00 (2.09) 1.50 (1.37) 2.00 (2.09)
Intestine
DSC. (SD) 0.77 (0.13) 0.74 (0.15) 0.77 (0.13) 0.87 (0.03) 0.93 (0.04) 0.93 (0.02) + ^
Sensitivity. (SD) 0.75 (0.21) 0.68 (0.21) 0.74 (0.21) 0.90 (0.05) 0.90 (0.06) 0.95 (0.01) * ° ^
IncI. (SD) 0.85 (0.09) 0.86 (0.08) 0.84 (0.10) 0.86 (0.07) 0.97 (0.03) 0.92 (0.04) * ° + ^ =
ΔV (%). (SD) −9.54 (30.30) −19.36 (29.33) −9.7 (31.47) 5.46 (14.22) −7.48 (5.73) 2.98 (5.13) * ° + =
Δx (mm). (SD) 2.94 (1.36) 4.90 (4.77) 4.52 (5.51) 2.08 (1.21) 1.58 (1.05) 1.08 (1.10) ^
Δy (mm). (SD) 4.12 (4.23) 4.20 (4.05) 4.70 (3.83) 1.86 (1.55) 1.48 (0.67) 1.86 (2.54)
Δz (mm). (SD) 11.50 (8.40) 12.00 (7.37) 12.00 (7.16) 3.00 (4.11) 0.00 (0.00) 1.00 (1.37)
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Table 4 Mean values and standard deviations of parameters that evaluate the contours generated by the three
software, before and after the manual correction, for each organ of the mesothelioma patients (Continued)
Liver
DSC. (SD) 0.93 (0.02) 0.93 (0.03) 0.90 (0.01) 0.93 (0.03) 0.97 (0.02) 0.95 (0.02) # ° +
Sensitivity. (SD) 0.92 (0.02) 0.90 (0.03) 0.92 (0.03) 0.93 (0.03) 0.95 (0.03) 0.96 (0.02) ^
IncI. (SD) 0.93 (0.03) 0.95 (0.04) 0.88 (0.02) 0.93 (0.03) 0.98 (0.02) 0.94 (0.03) * # ° + =
ΔV (%). (SD) −0.80 (2.10) −5.08 (2.16) 5.44 (4.93) 0.00 (2.29) −2.96 (2.41) 2.26 (4.28) * ° + =
Δx (mm). (SD) 3.24 (2.53) 2.64 (1.81) 3.80 (2.26) 2.16 (1.90) 0.60 (0.65) 0.70 (0.45)
Δy (mm). (SD) 1.28 (1.11) 1.56 (1.09) 1.38 (0.70) 1.18 (1.27) 0.60 (0.55) 1.00 (0.70)
Δz (mm). (SD) 1.50 (2.24) 3.50 (2.85) 4.50 (3.26) 2.50 (1.77) 1.00 (1.37) 1.00 (1.37)
Kidney left
DSC. (SD) 0.89 (0.02) 0.87 (0.03) 0.81 (0.06) 0.91 (0.01) 0.95 (0.02) 0.92 (0.02) * # ° =
Sensitivity. (SD) 0.88 (0.05) 0.84 (0.06) 0.81 (0.12) 0.93 (0.02) 0.92 (0.03) 0.91 (0.02) * #
IncI. (SD) 0.89 (0.02) 0.90 (0.03) 0.82 (0.04) 0.88 (0.02) 0.98 (0.03) 0.93 (0.04) * # ° + =
ΔV (%). (SD) −0.98 (7.21) −7.40 (8.71) −1.40 (15.64) 4.90 (4.36) −6.08 (3.41) −1.10 (5.61) * +
Δx (mm). (SD) 0.90 (0.74) 1.10 (0.65) 1.30 (0.57) 0.80 (0.57) 0.50 (0.50) 1.00 (0.79)
Δy (mm). (SD) 0.60 (0.42) 0.70 (0.84) 1.18 (1.11) 0.40 (0.22) 0.20 (0.27) 0.50 (0.36)
Δz (mm). (SD) 2.00 (1.12) 4.00 (2.85) 6.50 (5.18) 1.50 (1.37) 0.00 (0.00) 0.00 (0.00)
Kidney right
DSC. (SD) 0.89 (0.02) 0.86 (0.04) 0.83 (0.05) 0.91 (0.02) 0.95 (0.02) 0.93 (0.01) #
Sensitivity. (SD) 0.88 (0.04) 0.83 (0.06) 0.81 (0.10) 0.93 (0.03) 0.91 (0.03) 0.92 (0.02) #
IncI. (SD) 0.90 (0.05) 0.91 (0.05) 0.86 (0.09) 0.89 (0.05) 0.99 (0.02) 0.94 (0.02) # ° + ^ =
ΔV (%). (SD) −1.92 (9.47) −8.68 (8.81) −4.30 (17.24) 4.28 (7.74) −7.72 (1.43) −2.46 (3.08) + ^ =
Δx (mm). (SD) 1.46 (1.13) 1.06 (1.24) 1.10 (0.74) 0.80 (0.76) 0.60 (0.42) 0.50 (0.71)
Δy (mm). (SD) 0.60 (0.55) 0.70 (0.45) 1.08 (1.70) 0.60 (0.55) 0.50 (0.35) 0.80 (0.57)
Δz (mm). (SD) 3.50 (2.85) 3.00 (4.11) 5.00 (6.37) 1.00 (1.37) 0.50 (1.12) 0.50 (1.12)
Spinal cord
DSC. (SD) 0.71 (0.07) 0.69 (0.08) 0.74 (0.06) 0.73 (0.04) 0.83 (0.02) 0.86 (0.05) # ° ^
Sensitivity. (SD) 0.65 (0.15) 0.61 (0.16) 0.74 (0.16) 0.69 (0.12) 0.72 (0.18) 0.85 (0.11) * # ° ^
IncI. (SD) 0.82 (0.15) 0.85 (0.13) 0.78 (0.12) 0.83 (0.14) 1.00 (0.00) 0.88 (0.06) * # ° + =
ΔV (%). (SD) −15.72 (32.61) −24.9 (31.50) −0.72 (34.59) −12.86 (31.11) −27.76 (18.01) −3.02 (16.70) * # ° =
Δx (mm). (SD) 1.00 (0.61) 0.80 (0.27) 0.40 (0.42) 1.00 (0.61) 0.30 (0.45) 0.40 (0.65)
Δy (mm). (SD) 4.70 (5.93) 4.40 (4.90) 4.02 (4.06) 4.70 (5.93) 0.80 (0.67) 0.2 (0.27)
Δz (mm). (SD) 22.00 (23.21) 22.00 (22.87) 21.50 (21.84) 9.00 (8.94) 3.00 (4.11) 1.00 (2.24)
Spleen
DSC. (SD) 0.92 (0.01) 0.90 (0.03) 0.84 (0.04) 0.93 (0.01) 0.95 (0.02) 0.94 (0.01) # ° =
Sensitivity. (SD) 0.90 (0.00) 0.86 (0.03) 0.88 (0.02) 0.92 (0.01) 0.92 (0.02) 0.94 (0.01) ^
IncI. (SD) 0.93 (0.02) 0.96 (0.03) 0.80 (0.06) 0.94 (0.01) 0.99 (0.02) 0.93(0.03) * # ° +
ΔV (%). (SD) −3.85 (2.04) −10.38 (2.89) 9.90 (10.45) −3.00 (1.12) −6.73 (1.16) 1.18 (4.04) * +
Δx (mm). (SD) 0.75 (0.65) 0.88 (0.48) 1.00 (0.41) 1.48 (0.78) 0.50 (0.00) 0.75 (0.64)
Δy (mm). (SD) 2.58 (2.89) 2.95 (2.61) 3.58 (3.49) 1.73 (1.51) 1.00 (0.58) 1.75 (0.29)
Δz (mm). (SD) 2.50 (2.04) 1.88 (2.93) 3.75 (2.23) 1.25 (1.44) 0.00 (0.00) 1.88 (2.39)
For automatic segmentation: *AA vs. MA: p<0.043, #AA vs. VA: p<0.043, °MA vs. VA: p<0.043.
For automatic segmentation+ manual correction: +AM vs. MM: p<0.043, ^AM vs. VM: p<0.043, =MM vs. VM: p<0.043.
Abbreviations: CTV = Clinical target volume; SD = Standard deviation, DSC = DICE similarity coefficient, IncI = inclusiveness index, AA = Abas Automatic, MA = MiM
Automatic, VA = Velocity Automatic, AM = Abas Manual Correction, MM = MiM Manual Correction, VM = Velocity Manual Correction.
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Figure 2 mROC analysis of the performances of three software
solutions evaluated for some OARs of prostate patients:
a) rectum, b) bladder, and c) bowel. Automatic segmentation and
automatic segmentation+ correction were compared to the manual
contours from scratch.
Figure 3 mROC analysis of the performances of three software
solutions evaluated in H&N patients: a) optical nerve, b) spinal
cord, and c) cochlea right. Automatic segmentation and automatic
segmentation + correction were compared to the manual contours
from scratch.
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http://www.ro-journal.com/content/7/1/160three tumor sites. For the purpose of this study, con-
tours of manually-generated VOIs on pCT were taken as
a reference atlas. These were then compared to the
VOIs (contours) automatically generated by A, M and V,
and successively corrected manually. This procedure
has proved to be time saving although the AC must be
re-checked and corrected manually by physicians: on
average, about 40 minutes were saved for the HRPCa,
one hour for the H&N patients, and 20 minutes for
the MPM.
Regarding prostate cases, the auto-segmentation mod-
ule faces the same problems as the clinicians when
drawing the prostate: a) in the cranial direction there is
poor or no contrast on the CT between the base of theprostate and the bladder, b) in the caudal direction, there
is poor or no contrast between the apex of the prostate
and the rectum. As in the correction/replanning of the
prostate plans, the volumes that needed the most correc-
tions were the rectum, the CTV and the bowel. The
volumes closer to the reference volumes were the fem-
oral heads and the bladder. It was noted that the most
cranial and caudal slices of all volumes underwent more
changes leading to greater intraobserver variability. This
was especially true for certain organs, such as the rec-
tum (Figure 5) (i.e. we also found that after manual cor-
rection, the ΔV and Δz parameter can remain significant
for some organs). For the Vref, the rectum was
Figure 4 mROC analysis of the performances of three software
solutions evaluated in mesothelioma patients: a) esophagus,
b) heart, and c) liver. Automatic segmentation and automatic
segmentation + correction were compared to the manual contours
from scratch.
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AC, these anatomical limits were not always respected.
This may lead to the intraobserver variability: the AC
could bring us to correct a contour that is misleading
from the start for the physician. The placement of a
rectal balloon and a strict protocol for bladder filling
could help the automatic recontouring process for the
prostate patient.
With regards to the H&N cases, the first consideration
is that the re-planning CT was performed without con-
trast media; surely having contrast media would have
been helpful for the physician for target delineation and
probably for the three software packages too. Nonethe-
less results, both in terms of time and contouring accur-
acy are good and promising. All three software solutionssignificantly reduce the time needed to replan the VOIs
in comparison to the time needed to replan the same
VOIs from scratch (Vref ). Indeed, both the automatic
contouring time, the manual correction time and their
sum are statistically shorter than the Vref contouring
time. Each software allows 1 hour to be saved, which is
undoubtedly relevant in daily clinical activity. The sig-
nificant differences found amongst the times provided
by the three software packages can be explained in part
with the fact that the referring contouring physician for
the H&N area had been using one of them in his clinical
practice during the months preceding the analysis.
When evaluating quality according to the established
parameters, ΔV, Δx,y,z, DSC, sensitivity and inclusive-
ness indexes, VOIs generated with the AC and VOIs
manually corrected from AC compares favourably with
their corresponding Vref VOIs. Indeed even lower scores
of the quality indexes are in an acceptable range. As for
the prostate cases, we found a volume variation between
the Vref VOIs and the automatic generated manually
corrected VOIs in particular for CTVs, for organs with
not-precisely-defined boundaries such as the superior
pharynx and for organs of small volume such as the
cochlea. This intra-observer variability is a well known
phenomenon of the radiotherapy planning more evident
when there are no anatomical points of reference. As for
rectum, another explanation could be that automatic
contour propagation produce contours which somehow
"suggest" to the human observer incorrect contour
shape. Variation in the position of center of mass is par-
ticularly evident for the z axis both for automatically
generated and manually corrected but it is limited to the
length of a couple of slices. As expected, scores of DSC,
sensitivity and inclusiveness indexes for ACMC contours
are better than the automatically generated correspond-
ing ones, pointing out the necessity of correction from a
physician of the automatically generated VOIs.
In the mesothelioma cases the bowel required some
work to be re-contoured manually particularly in the most
cranial and caudal slices. Moreover, thoracic cavity showed
some differences probably for a different content of air
cavities, requesting some more manual interventions.
The accuracy evaluated with sensitivity, inclusiveness
and DSC indexes, and the other volumetric parameters,
show that none of the three software solutions always
perform better: depending on the VOI, parameter and
type of cancer considered, from time to time one soft-
ware can be better than another. More importantly, a
statistically significant difference between the software
solutions does not lead to a clinically relevant difference.
Looking at the data reported in our tables (Tables 2, 3
and 4), it is up to the clinician to assess what might be
the most suitable software for the specific patient/proto-
col. We also have to emphasize that the presence of
Figure 5 Patient manually contoured from scratch (red), automatically segmented (green) by the three software solutions and
corrected after automatic segmentation (yellow) for a HRPCa, a H&N case, and a MPM.
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http://www.ro-journal.com/content/7/1/160artifacts or relevant anatomical changes (bowel shape or
filling, nasal cavity empty or full, etc.) could seriously
affect the quality of the automatic contours generation.
Moreover, the three commercial software solutions have
other differences that were not evaluated in this study. We
can observe that A is the only one that doesn’t have its
own contouring tools: another software to import and re-
view the results of the deformation is needed. On the other
hand A is a simple and straightforward software for auto-
matic contour generation. Both V and M have tools for the
deformable registration of CT images, cumulative dose vol-
ume histogram calculation, and V manages also the de-
formable registration of MRI with CT images (useful for
treatment planning on brain, prostate and for paediatric
patients), but we did not test the reliability of such tools. M
required more time to learn how to operate the software.
In the context of on-line adaptive treatment, both auto-
matic delineation of CTV and OARs are important. In
general, we can say the higher the sensitivity of the OARs
automatic segmentation, the lower the risk for overirradiation of the organs; the higher the sensitivity of the
CTV segmentation, the lower the risk for under irradi-
ation of tumor tissue. On the other hand, as discussed by
Tsuji et al. [7], it is difficult to determine a priori whether
automatic contours have acceptable accuracy because the
importance lies also in the dosimetry of their resultant
plans. Tsuji et al. found differences in target coverage and
conformality with a similar range of DSC and also Voet
et al. [6] found underdosages in the PTV of up to 11 Gy
even for DSC coefficients of 0.8. Furthermore, in the Tsuji
et al. statistical analysis, a significant correlation between
the overlapping index, what we call “sensitivity index”,
and the target coverage was shown. Tsuji et al. concluded
that because of its stronger correlation with target cover-
age, the sensitivity index may be a better initial measure to
predict contour utility, as opposed to DSC. We didn’t
evaluate the dosimetric effects of our contour discrepan-
cies, but we believe that each protocol for automatic
recontouring should also be evaluated also from this point
of view. This will be the goal for our future research.
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contours to daily diagnostic CT images, instead of daily
MVCT or kV CT, would facilitate adaptive replanning. De-
formable image registration relies on image quality. In the
present study, we used CT images from a fan-beam CT
scanner. Our current automatic ROI delineation method
can be directly applied to IGRT by CT-on-rail positioned
in the treatment room. The image quality of Cone beam
CT-CBCT is inferior to that of a fan-beam CT scanner.
More importantly, the signal/noise ratio is dramatically
low compared to the one of regular fan-beam CT images.
If the contours are available on daily CT images, dose–
volume histograms can be calculated to evaluate the ne-
cessity of replanning, or the contours can be used directly
for intensity-modulated RT optimization. In addition, the
daily dose distribution can be transformed back to the
planning CT scan by using the same deformable image
registration method to compare it to the original plan and
estimate the cumulative doses delivered to the patient.
Conclusion
The AC workflow was shown to be significantly shorter
than the manual contouring process from scratch, even
though manual correction of the VOIs is always needed.
For the H&N site, a clinician can save about one hour, for
a prostate patient, the time saved is about 40 minutes, and
for a mesothelioma patient about 20 minutes. The differ-
ences, both in time and quality, between the software
packages were statistically significant in many cases, but
the absolute values of such differences are often modest.
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